These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 28606001)

  • 21. Procoagulant microparticles: a possible link between vaccine-induced immune thrombocytopenia (VITT) and cerebral sinus venous thrombosis.
    Marchandot B; Carmona A; Trimaille A; Curtiaud A; Morel O
    J Thromb Thrombolysis; 2021 Oct; 52(3):689-691. PubMed ID: 34129181
    [No Abstract]   [Full Text] [Related]  

  • 22. [Heparin-induced thrombocytopenia: a brief update in an Italian perspective].
    Prisco D
    Recenti Prog Med; 2007 Sep; 98(9):452-6. PubMed ID: 17902571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Testing for heparin-induced thrombocytopenia: are we there yet?
    Arnold DM; Kelton JG
    J Thromb Haemost; 2007 Jul; 5(7):1371-2. PubMed ID: 17439627
    [No Abstract]   [Full Text] [Related]  

  • 24. Incidence of isolated heparin-induced thrombocytopenia and risk of thrombosis by IgG-specific anti-PF4/heparin ELISA.
    Radaideh SM; Frenkel EP; Dowell JE; Sarode R; Shen YM
    Clin Appl Thromb Hemost; 2012; 18(2):215-7. PubMed ID: 22067544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet factor 4/heparin complexes present epitopes differently on solid-phase vs platelet surfaces.
    Nguyen TH; Greinacher A
    Blood; 2017 Jun; 129(26):3498-3501. PubMed ID: 28476748
    [No Abstract]   [Full Text] [Related]  

  • 26. Anti-heparin-platelet factor 4 antibodies are associated with arterial and venous thrombosis in patients with maintenance haemodialysis.
    Tan Y; Cao L; Lv JC; Yan Y; Zuo L; Wang M; Yu L; Yu F; Zhao MH
    Thromb Haemost; 2009 Dec; 102(6):1282-4. PubMed ID: 19967164
    [No Abstract]   [Full Text] [Related]  

  • 27. Fondaparinux-related thrombocytopenia in a patient with former HIT. Response to Rota et al. (Thromb Haemost 2008; 99: 779-781).
    Schindewolf M; Lindhoff-Last E
    Thromb Haemost; 2008 Jul; 100(1):168-9; author reply 169-70. PubMed ID: 18612559
    [No Abstract]   [Full Text] [Related]  

  • 28. Detection of anti-heparin-PF4 complex antibodies in COVID-19 patients on heparin therapy.
    Dragonetti D; Guarini G; Pizzuti M
    Blood Transfus; 2020 Jul; 18(4):328. PubMed ID: 32697931
    [No Abstract]   [Full Text] [Related]  

  • 29. Post-operative platelet count profile: the most reliable tool for identifying patients with true heparin-induced thrombocypenia after cardiac surgery.
    Gruel Y; Pouplard C
    J Thromb Haemost; 2010 Jan; 8(1):27-9. PubMed ID: 19817999
    [No Abstract]   [Full Text] [Related]  

  • 30. Heparin-induced thrombocytopenia: a ten-year retrospective.
    Warkentin TE
    Annu Rev Med; 1999; 50():129-47. PubMed ID: 10073268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Bilateral adrenal hemorrhage after heparin-induced thrombocytopenia, a rare cause of shock].
    Reverdy F; Freichet M; Grozel JM; Tassin C; Piriou V
    Ann Fr Anesth Reanim; 2013 Mar; 32(3):206-7. PubMed ID: 23474000
    [No Abstract]   [Full Text] [Related]  

  • 32. HITlights: a career perspective on heparin-induced thrombocytopenia.
    Warkentin TE
    Am J Hematol; 2012 May; 87 Suppl 1():S92-9. PubMed ID: 22367928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequency of anti-heparin-PF4 complex antibodies (HIT antibodies) in uremic patients on chronic intermittent hemodialysis.
    Matsuo T; Kobayashi H; Matsuo M; Wanaka K; Nakamoto H; Matsushima H; Sakai R
    Pathophysiol Haemost Thromb; 2006; 35(6):445-50. PubMed ID: 17565238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pathophysiology of heparin-induced thrombocytopenia: biological basis for treatment.
    Kelton JG
    Chest; 2005 Feb; 127(2 Suppl):9S-20S. PubMed ID: 15706026
    [No Abstract]   [Full Text] [Related]  

  • 35. Heparin-dependent platelet antibodies in children: problem or merely problematic?
    Parker RI
    Pediatr Crit Care Med; 2007 Jul; 8(4):404-5. PubMed ID: 17622926
    [No Abstract]   [Full Text] [Related]  

  • 36. The identification and management of heparin-induced thrombocytopenia in the vascular patient.
    LaMuraglia GM; Houbballah R; Laposata M
    J Vasc Surg; 2012 Feb; 55(2):562-70. PubMed ID: 22188737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identifying patients at high risk of heparin-induced thrombocytopenia-associated thrombosis with a platelet activation assay using flow cytometry.
    Maeda T; Nakagawa K; Murata K; Kanaumi Y; Seguchi S; Kawamura S; Kodama M; Kawai T; Kakutani I; Ohnishi Y; Kokame K; Okazaki H; Miyata S
    Thromb Haemost; 2017 Jan; 117(1):127-138. PubMed ID: 27734072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heparin-induced thrombosis without thrombocytopenia.
    Tibayan FA; Leung LL; Burdon TA; Fann JI
    J Thorac Cardiovasc Surg; 2010 Feb; 139(2):e6-7. PubMed ID: 19660256
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical practice. Heparin-induced thrombocytopenia.
    Arepally GM; Ortel TL
    N Engl J Med; 2006 Aug; 355(8):809-17. PubMed ID: 16928996
    [No Abstract]   [Full Text] [Related]  

  • 40. [Heparin induced autoimmune thrombocytopenia: assessment of a rapid functional assay].
    Lasne D; Tabet K; Bachelot C; Aiach M
    Ann Biol Clin (Paris); 2001; 59(4):423-9. PubMed ID: 11470637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.